VNP: Interactive visual network pharmacology of diseases, targets, and drugs

CPT: Pharmacometrics and Systems Pharmacology

Volumn 3, Issue 3, 2014, Pages

  Hu, Q N ^a   Deng, Z ^a   Tu, W ^a   Yang, X ^a   Meng, Z B ^a   Deng, Z X ^a   Liu, J ^a  

^a WUHAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINESTERASE; ALPHA 2 ADRENERGIC RECEPTOR; CHOLINERGIC RECEPTOR; MUSCARINIC RECEPTOR;

ALZHEIMER DISEASE; AMINO ACID SEQUENCE; ARTICLE; DATA BASE; DRUG DEVELOPMENT; DRUG STRUCTURE; DRUG TARGETING; HUMAN; INTERMETHOD COMPARISON; INTERNET; PHARMACOLOGY; PRIORITY JOURNAL; TREATMENT OUTCOME; VISUAL NETWORK PHARMACOLOGY;

EID: 84902525726     PISSN: None     EISSN: 21638306     Source Type: Journal    
DOI: 10.1038/psp.2014.1     Document Type: Article

References (27)

1. Gashaw, I., Ellinghaus, P., Sommer, A. & Asadullah, K. What makes a good drug target? Drug Discov. Today 16, 1037-1043 (2011).
2. Chen, X., Ji, Z.L. & Chen, Y.Z. TTD: Therapeutic Target Database. Nucleic Acids Res. 30, 412-415 (2002). (Pubitemid 34679600)
3. Ainsworth, C. Networking for new drugs. Nat. Med. 17, 1166-1168 (2011).
4. Csermely, P., Korcsmáros, T., Kiss, H.J., London, G. & Nussinov, R. Structure and dynamics of molecular networks: a novel paradigm of drug discovery: a comprehensive review. Pharmacol. Ther. 138, 333-408 (2013).
5. Hu, G. & Agarwal, P. Human disease-drug network based on genomic expression profiles. PLoS ONE 4, e6536 (2009).
6. Nobeli, I., Favia, A.D. & Thornton, J.M. Protein promiscuity and its implications for biotechnology. Nat. Biotechnol. 27, 157-167 (2009).
7. Schrattenholz, A., Groebe, K. & Soskic, V. Systems biology approaches and tools for analysis of interactomes and multi-target drugs. Methods Mol. Biol. 662, 29-58 (2010).
8. Mencher, S.K. & Wang, L.G. Promiscuous drugs compared to selective drugs (promiscuity can be a virtue). BMC Clin. Pharmacol. 5, 3 (2005).
9. Hopkins, A.L., Mason, J.S. & Overington, J.P. Can we rationally design promiscuous drugs? Curr. Opin. Struct. Biol. 16, 127-136 (2006). (Pubitemid 43221881)
10. Hopkins, A.L. Network pharmacology: the next paradigm in drug discovery. Nat. Chem. Biol. 4, 682-690 (2008).
11. Frantz, S. Drug discovery: playing dirty. Nature 437, 942-943 (2005).
12. Hamosh, A., Scott, A.F., Amberger, J.S., Bocchini, C.A. & McKusick, V.A. Online Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders. Nucleic Acids Res. 33, D514-D517 (2005). (Pubitemid 40207927)
13. Knox, C. et al. DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Nucleic Acids Res. 39, D1035-D1041 (2011).
14. Liu, T., Lin, Y., Wen, X., Jorissen, R.N. & Gilson, M.K. BindingDB: a web-accessible database of experimentally determined protein-ligand binding affinities. Nucleic Acids Res. 35, D198-D201 (2007). (Pubitemid 46056198)
15. Zhu, F. et al. Therapeutic target database update 2012: a resource for facilitating targetoriented drug discovery. Nucleic Acids Res. 40, D1128-D1136 (2012).
16. Lechner, M. et al. CIDeR: multifactorial interaction networks in human diseases. Genome Biol. 13, R62 (2012).
17. Waldman, S.A., van der Graaf, P.H. & Terzic, A. Systems approaches evolve clinical pharmacology. CPT. Pharmacometrics Syst. Pharmacol. 2, e68 (2013).
18. Kirouac, D.C. & Onsum, M.D. Using network biology to bridge pharmacokinetics and pharmacodynamics in oncology. CPT. Pharmacometrics Syst. Pharmacol. 2, e71 (2013).
19. Go, A.S. et al. An Effective Approach to High Blood Pressure Control: A Science Advisory From the American Heart Association, the American College of Cardiology, and the Centers for Disease Control and Prevention. Hypertension in press (2014).
20. Michalopoulou, P.G., Azim, A., Tracy, D. & Shergill, S.S. Ropinirole as an effective adjunctive treatment for clozapine-resistant negative symptoms in simple schizophrenia: a case report. J. Clin. Psychopharmacol. 32, 719-720 (2012).
21. Bostwick, J.M., Hecksel, K.A., Stevens, S.R., Bower, J.H. & Ahlskog, J.E. Frequency of new-onset pathologic compulsive gambling or hypersexuality after drug treatment of idiopathic Parkinson disease. Mayo Clin. Proc. 84, 310-316 (2009).
22. Cao, D.S. et al. Genome-scale screening of drug-target associations relevant to Ki using a chemogenomics approach. PLoS ONE 8, e57680 (2013).
23. Hu, Q.N., Deng, Z., Hu, H., Cao, D.S. & Liang, Y.Z. RxnFinder: biochemical reaction search engines using molecular structures, molecular fragments and reaction similarity. Bioinformatics 27, 2465-2467 (2011).
24. Smith, T.F. & Waterman, M.S. Identification of common molecular subsequences. J. Mol. Biol. 147, 195-197 (1981).
25. Pearson, W.R. & Lipman, D.J. Improved tools for biological sequence comparison. Proc. Natl. Acad. Sci. U.S.A. 85, 2444-2448 (1988).
26. Lipman, D.J. & Pearson, W.R. Rapid and sensitive protein similarity searches. Science 227, 1435-1441 (1985). (Pubitemid 15146986)
27. Fruchterman, T.M.J. & Reingold, E.M. Graph drawing by force-directed placement. Software: Practice Experience 21, 1129-1164 (1991).